Announcements

Announcements Files
Intimation of Partnership with Redcliffe labs 01st Dec 2022 View
Agreement with India’s top most institute – IIT,Bombay 04th Jan 2023 View
Announcement 10th January 2023 View
Announcement 11th January 2023 View
Agreement for appointment of Mr.Kapil Dev as Brand Ambassador 16th Jan 2023 View
Announcement under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 07th Feb 2023. View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 16th Feb 2023. View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, 17th Feb 2023. View
Intimation for closure of Trading Window, 31st March 2023. View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 31st March 2023. View
Non-applicability of Corporate Governance Report as per Regulation 27(2) of SEBI (LODR) Regulations, 2015 View
Certificate under regulation 76 of the SEBI (Depositories and Participants) Regualtion, 2018 for the Quarter ended MARCH 31, 2023. View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. View
COMPLIANCE under Regulation 40(9) AND 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended MARCH 31, 2023 View
COMPLIANCE under Regulation 7(3) OF THE SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended MARCH 31, 2023 View
Disclosure of Non-applicability of SEBI Circular dated November 26, 2018 with regard to fund raising by issuance of debt securities by large entities View
Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) Regulations View
Deviation and Variation Letter View
Letter of RPT View
Non-applicability of CG View
CERTIFICATE UNDER REGULATION 74(5) OF THE SEBI (DEPOSITORIES AND PARTICIPANTS) REGULATIONS, 2018 FOR THE QUARTER ENDED JUNE 30, 2023 View
SUBMISSION OF STATEMENT OF INVESTOR GRIEVANCES AS REQUIRED UNDER REGULATION 13(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATION, 2015 FOR THE QUARTER ENDED JUNE 30, 2023G View
Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) Regulations View
Statement of Deviation or Variation Pursuant to Reg. 32 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, for the Quarter ended 30th June, 2023. View
Outcome of the meeting of Board of Directors pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. View
Newspaper Advertisement – Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). View
Newspaper Advertisement – Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). View
Book Closure and Record date for Dividend and Annual General Meeting. View
Newspaper Publication for Notice of AGM. View
Investor Presentation. View
Schedule of Analysts/Investors Meeting. View
Reschedule of Analysts/Investors Meeting. View
Update of Analysts/Investors Meeting. View
Proceedings of 06th Annual General Meeting. View
Voting Results and Scrutinizer Report of 06th Annual General Meeting. View
Trading window closure. View
Non Applicability of Corporate Governance. View
Certificate under Regulation 76 Of The SEBI (Depositories and Participants) Regulations, 2018 For The Quarter Ended SEPTEMBER 30, 2023. View
Submission Of Statement Of Investor Grievances As Required Under Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Quarter Ended September 30, 2023. View
Certificate under Regulation 74(5) Of The SEBI (Depositories and Participants) Regulations, 2018 For The Quarter Ended September 30, 2023. View
Intimation of Term sheet for Acquisition of Saarathi Healthcare Private Limited. View
Intimation o Term Sheet for Acquisition of Prometheus Healthcare Private Limited. View
Intimation of Board Meeting. View
Press Release. View
Investor Presentation. View
Copy of Newspaper Publication. View
Intimation of Investor call in December 04, 2023. View
Intimation of Reschedule of Investor call on December 08, 2023. View
Outcome of Investor call held on December 08, 2023. View
Voting Results and Scrutinizer report for the meeting held by Postal Ballot. View
Trading window closure. View
Schedule of Investor Meet. View
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended DECEMBER 31, 2023. View
Submission of Statement of Investor Grievances as required under Regualation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions, 2015 for the Quarter ended DECEMBER 31, 2023. View
Certificate under Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended DECEMBER 31, 2023. View
Non-applicability of Corporate Governance Report as per Regulation 27(2) of SEBI (LODR) Regulations, 2015. View
Outcome of Investor call held on January 17, 2024. View
Intimation of Board Meeting to be held on February 02, 2024. View
Outcome of Board Meeting held on February 02, 2024. View
Announcement copy of Newspaper Publication. View
Intimation of Board Meeting to be held on February 13, 2024. View
Statement of Deviation and variation. View
Intimation for execution of Share Purchase Agreement in relation to acquisition of stake in Saarathi Healthcare Private Limited. View
Press Release – Share Purchase Agreement regarding Acquisition of 51% stake in Saarathi Healthcare Private Limited. View
Press Release – Unaudited Financial Results of the Company for the quarter ended December 31, 2023. View
Investor Presentation for the quarter ended December 31, 2023. View
Valuation report dated January 27, 2024. View
CS Certificate . View
Proceedings of First Extra-Ordinary General Meeting held on February 26,2024. View
Intimation of Analysts/Investors Meeting. View
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. View
Voting Results and Scrutinizer Report of the 1st Extra Ordinary General Meeting (‘EGM’). View
Voting Results and Scrutinizer Report of the 1st Extra Ordinary General Meeting (‘EGM’). View
Intimation of Investor meet to be held on March 07, 2024. View
Intimation of cancellation of Investor meet held on February 29, 2024. View
Outcome of Investor call held on March 07, 2024. View
Intimation of Trading window. View
Certificate under regualation 74(5) of the SEBI (DEPOSITORIES AND PARTICIPANTS) Regulations, 2018 for the Quarter ended MARCH 31, 2024. View
Statement of Investor Grievances as requires under Regulation 13(3) of the SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) Regulation, 2015 for the Quarter ended MARCH 31, 2024. View
Non-applicability of Corporate Governance Report as per Regulation 27(2) of SEBI (LODR) Regulations, 2015. View
Compliance under Regualtion 7(3) of the SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) Regulations, 2015 for the year ended MARCH 31, 2024. View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. View
Announcement under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. View
Disclosure of Non-applicability of SEBI Circular dated November 26, 2018 with regard to fund raising by issuance of debt securities by large entities. View
Compliance under Regulation 40(9) and 40(10) of the SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) Regulations, 2015 for the year ended MARCH 31, 2024. View
Certificate under Regulation 76 of the SEBI (DEPOSITORIES AND PARTICIPANTS) Regulations, 2018 for the Quarter ended MARCH 31, 2024. View
Intimation for Investor call to be held on May 09, 2024. View
Cancellation for Investor call held on May 09, 2024. View
Intimation of Board Meeting to be held on May 23, 2024. View
Intimation of Investor call held on May 20, 2024 at 10.30 AM. View
Intimation of Investor call held on May 20, 2024 at 02.00 PM. View
Intimation of Earning Call to be held on May 24, 2024. View
Outcome of Board Meeting held on May 23, 2024. View
Statement of Deviation and Variation. View
Related Party Transactions. View
Earning Press Release dated May 24, 2024. View
Investor Presentation for Quarter 4 Financial Year 2024. View
Withdrawal of Preferential issue. View
Outcome of Board Meeting held on June 06, 2024. View
Intimation of Investor call to be held on June 22, 2024. View
Intimation for Closure of Trading Window for the first quarter ended June 30, 2024. View
Intimation of Investor call to be held on July 03, 2024. View
Intimation for Amendment in Share Purchase Agreement with Saarathi Healthcare Private Limited. View
Intimation of Acquisition of 51% stake in the Equity Share Capital of Saarathi Healthcare Private Limited. View
Non Applicability of Corporate Governance. View
STATEMENT OF INVESTOR GRIEVANCES AS REQUIRED UNDER REGULATION 13(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATION, 2015 FOR THE QUARTER ENDED JUNE 30, 2024. View
CERTIFICATE UNDER REGULATION 74(5) OF THE SEBI (DEPOSITORIES AND PARTICIPANTS) REGULATIONS, 2018 FOR THE QUARTER ENDED JUNE 30, 2024. View
Certificate under Regulation 76 Of The SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2024. View